2011
DOI: 10.1016/j.yexmp.2011.04.018
|View full text |Cite
|
Sign up to set email alerts
|

Localization of Epstein-Barr virus to infiltrating lymphocytes in breast carcinomas and not malignant cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
20
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 26 publications
(23 citation statements)
references
References 40 publications
2
20
0
Order By: Relevance
“…All five EBV positive women were postmenopausal, and were on average 10 years older than the EBV negative women (66 and 56 years old, respectively), however this age difference was not statistically significant (p = 0.09). In a recent paper, the EBV positive cells in breast tumours were found to be infiltrating lymphocytes, while no virus was detected in the malignant breast cells [24]. Due to insufficient original sample quantities, we were not able to perform in situ hybridisation or immunohistochemistry on the EBV positive samples, and thus, could not determine the cellular origin of the detected virus.…”
Section: Resultsmentioning
confidence: 88%
“…All five EBV positive women were postmenopausal, and were on average 10 years older than the EBV negative women (66 and 56 years old, respectively), however this age difference was not statistically significant (p = 0.09). In a recent paper, the EBV positive cells in breast tumours were found to be infiltrating lymphocytes, while no virus was detected in the malignant breast cells [24]. Due to insufficient original sample quantities, we were not able to perform in situ hybridisation or immunohistochemistry on the EBV positive samples, and thus, could not determine the cellular origin of the detected virus.…”
Section: Resultsmentioning
confidence: 88%
“…A study of fibroadenoma tissue from immunosuppressed and non-immunosuppressed patients was positive for EBV using PCR but none of the fibroadenomas from non-immunosuppressed patients expressed LMP-1 protein, suggesting that EBV may be associated with fibroadenomas only in immunocompromised patients[41]. It has been suggested that EBV detected in breast tissue samples is present in lymphocytes rather than tumour cells[28, 52, 54] but others dispute this [14, 16, 38]. Finding EBV in infiltrating lymphocytes could be expected if breast cancer is, even in part, a response to an abnormal immune stimulus.…”
Section: Resultsmentioning
confidence: 99%
“…[24, 25] However, two earlier studies using QPCR of EBV and breast cancer found very low levels of EBV DNA in breast cancer tissue[26, 27] and a recent study using immunohistochemistry (IHC) and in situ hybridization (ISH) found EBV in infiltrating lymphocytes in breast cancer tissue but not in malignant cells. [28]…”
Section: Introductionmentioning
confidence: 99%
“…These cases have been previously studied and further details including ER, PR and HER2 status can be found in our previous publication (Khan et al , 2011). …”
Section: Methodsmentioning
confidence: 99%
“…In a proportion of cases, no identifiable risk factor can be identified, prompting the idea that an oncogenic virus may be involved (Amarante and Watanabe, 2009). Indeed, several viruses have been implicated over the years (Labrecque et al , 1995; Bonnet et al , 1999; Melana et al , 2007; Cox et al , 2010; Glenn et al , 2010; Ariad et al , 2011), but none have conclusively been demonstrated to be central to the disease process (Chu et al , 2001; Herrmann and Niedobitek, 2003; Murray, 2006; Larrey et al , 2010; Khan et al , 2011; Silva and da Silva, 2011). …”
mentioning
confidence: 99%